Unilife Corp (UNIS)

0.09
0.00 0.12
OTC : Health Care
Prev Close 0.08
Open 0.08
Day Low/High 0.07 / 0.09
52 Wk Low/High 0.05 / 3.53
Volume 3.71K
Avg Volume 447.70K
Exchange OTC
Shares Outstanding 18.15M
Market Cap 2.90M
EPS -7.00
Div & Yield N.A. (N.A)

Stocks Under $10 Weekly Roundup

It was a busy week for the portfolio, as we closed 2 positions and added to 5 others.

Unilife (UNIS) Stock Lower on Jefferies Downgrade

Unilife (UNIS) Stock Lower on Jefferies Downgrade

Unilife (UNIS) price target was cut to $1.50 from $8.00 at Jefferies, which also lowered its rating to 'hold' from 'buy.'

Adding to Unilife on Weakness

The stock is volatile, but it could double.

Stocks Under $10 Weekly Roundup

This week, we used weakness to add to 4 positions as the market halted a losing streak.

Unilife Pumped by Product Launch, Financing

Shares respond well to debut of Imperium insulin patch pump and two financing steps.

Stocks Under $10 Weekly Roundup

This week, we added to 4 positions amid mixed earnings.

We're Adding to Position in Unilife

More pharmaceutical partnerships foreseen.

First Week Of March 2016 Options Trading For Unilife (UNIS)

First Week Of March 2016 Options Trading For Unilife (UNIS)

Investors in Unilife Corp. saw new options become available this week, for the March 2016 expiration.

Stocks Under $10 Weekly Roundup

No moves with the portfolio this week, but we're watching for some additions.

Stocks Under $10 Weekly Roundup

We took advantage of this week's volatility to initiate one position and add to 2 others.

Unilife (UNIS) Weak On High Volume Today

Unilife (UNIS) Weak On High Volume Today

Trade-Ideas LLC identified Unilife (UNIS) as a weak on high relative volume candidate

Stocks Under $10 Weekly Roundup

This week, we added to 2 positions in a volatile market as earnings season drew nearer.

Drawing Up a Potential Shopping List

With Greece-related weakness and our large cash position, we'll consider putting money to work.

Stocks Under $10 Weekly Roundup

We used weakness to add to 4 holdings in a volatile week for stocks.

We're Buying More SandRidge, Unilife

Putting cash to work while stocks are down.

Stocks Under $10 Weekly Roundup

We made several moves in the portfolio amid a volatile week for equities markets.

Stocks Under $10 Weekly Roundup

This week, we took advantage of market volatility to add a new position, book profits in some and add to others.

Stocks Under $10 Weekly Roundup

With an interest-rate hike looming, we took some profits in a banking position this week.

Sell These 7 Health Care Supplies Companies Now

Sell These 7 Health Care Supplies Companies Now

An aging population means the outlook is positive for health care equipment and supplies companies, but not every stock in the industry is a buy.

Stocks Under $10 Weekly Roundup

This week, we added to 3 portfolio positions and booked profits in another. Lots of economic reports ahead.

Buying Opportunity in Unilife

We'll take advantage of the broader market decline to add to this position.

Stocks Under $10 Weekly Roundup

This week, we added to one position after a pullback and are looking to do the same with others.

Unilife (UNIS) Is Weak On High Volume Today

Unilife (UNIS) Is Weak On High Volume Today

Trade-Ideas LLC identified Unilife (UNIS) as a weak on high relative volume candidate

First Week of July 17th Options Trading For Unilife (UNIS)

First Week of July 17th Options Trading For Unilife (UNIS)

Investors in Unilife Corp. saw new options begin trading this week, for the July 17th expiration.

Stocks Under $10 Weekly Roundup

We used a pullback in one holding to add to our position as earnings season ended.

Buying Unilife on Weakness

It's down 10% but the company's revenue doubled.

McDermott and Unilife Set to Report

We keep our Two rating on both into the print after the bell today.

Stocks Under $10 Weekly Roundup

This week, we added to 3 portfolio positions on early (before Friday) market weakness.

Stocks Under $10 Weekly Roundup

This week, we added to 2 portfolio positions amid market weakness.

Accumulating Unilife on Weakness

We believe the company will ramp production and continue to sign new pharmaceutical partners.